Empo Health, Inc.

Empo Health develops remote monitoring solutions for diabetic foot ulcer (DFU) prevention and management. The company's primary offering is the Empo Footprint imaging scale—a weight-scale form factor device that captures high-resolution images of patients' feet in a home setting—combined with the Empo Remote Health Link patient monitoring service. The system automatically transmits foot images to healthcare providers (podiatrists, primary care physicians, VA facilities) for review and clinical decision-making. The solution targets the 20+ million Americans with diabetic neuropathy who are at high risk for foot ulcers, amputation, and associated mortality. The company positions its offering as reducing the burden of routine foot monitoring on both patients (ease-of-use equivalent to stepping on a scale) and providers (automated image delivery and remote coordination). Clinical evidence cited on the site indicates remote DFU monitoring reduces amputation rates. The company serves podiatrists (DPM), family medicine, nurse practitioners, and health systems. Empo Health operates customer support and holds both product and service components; they maintain a dedicated support portal (support.empohealth.com) and phone/email support infrastructure.